IDEAS home Printed from https://ideas.repec.org/p/rff/dpaper/dp-96-21.html
   My bibliography  Save this paper

Thresholds for Carcinogens: A Review of the Relevant Science and It's Implications for Regulatory Policy

Author

Listed:
  • Wilson, James

Abstract

Regulation of carcinogens in the United States has been based on a "no threshold" policy. This makes the assumption there exists no level of exposure for which the possibility of causing harm is truly zero. The alternative "threshold" policy assumes that there exists some level of exposure at which no harm will come to anyone in a population so exposed. The no-threshold policy made sense when adopted, thirty or more years ago, since the science then available was not able to distinguish between these two opposing hypotheses, and "no threshold" provides more margin of safety. Since then, our understanding of biological processes related to birth and growth of cancer has greatly expanded. We now understand that two different biological processes can enlarge cancer risk. Increasing the rate at which cells divide is one of these; increasing the rate at which mutations occur, independently of cell division (mitotic) rate, is another. It is known that mitotic rate is under close physiologic control, operated through a complex system including a variety of intercellular messenger molecules. Functions controlled so as to be kept within certain limits in the face of external stressors must by definition exhibit a threshold in their response to small changes in such external stress. It is only necessary to demonstrate the existence of physiologic control to show that the threshold must exist. Thus there will be a threshold in the response to any nonmutagenic ("mitogenic") carcinogens. For classical mutagenesis as well, the weight of evidence favors the conclusion that thresholds exist. Evidence for "no threshold" has almost no weight, either because of the limits on our ability to measure response at very low levels of mutagenic stimulus, or because it springs from an unacknowledged tautology. Conversely, there is evidence of moderate weight, primarily that cancer rates are not elevated in areas of high background radiation flux, that the mutation rate is under active physiologic control. This expanded knowledge allows more reliable guidance for policy makers. First, policy should distinguish between "mitogenic" and "mutagenic" carcinogens, those that act predominantly by increasing the rate at which cells in certain tissues divide, and those that act directly on DNA. Mitogenic carcinogens should receive the same treatment as "noncarcinogens." At EPA, at least, policies are changing to reflect this understanding. Mutagenic carcinogens should be regulated using the "de minimus" approach FDA and EPA use for all cases other than direct food additives and pesticide residues. This approach relies on the concept of a "practical threshold," and provides very adequate protection of public health.

Suggested Citation

  • Wilson, James, 1996. "Thresholds for Carcinogens: A Review of the Relevant Science and It's Implications for Regulatory Policy," RFF Working Paper Series dp-96-21, Resources for the Future.
  • Handle: RePEc:rff:dpaper:dp-96-21
    as

    Download full text from publisher

    File URL: http://www.rff.org/RFF/documents/RFF-DP-96-21.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. James D. Wilson, 1991. "A Usually Unrecognized Source of Bias in Cancer Risk Estimations," Risk Analysis, John Wiley & Sons, vol. 11(1), pages 11-12, March.
    2. D. Krewski & D .W. Gaylor & A. P. Soms & M. Szyszkowicz, 1993. "An Overview of the Report: Correlation Between Carcinogenic Potency and the Maximum Tolerated Dose: Implications for Risk Assessment," Risk Analysis, John Wiley & Sons, vol. 13(4), pages 383-398, August.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Daniel Millimet & Daniel Slottje, 2003. "Industrial and environmental specialization," Applied Economics Letters, Taylor & Francis Journals, vol. 10(3), pages 123-128.
    2. James D. Wilson, 1997. "So Carcinogens Have Thresholds: How Do We Decide What Exposure Levels Should Be Considered Safe?," Risk Analysis, John Wiley & Sons, vol. 17(1), pages 1-3, February.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Wilson, James D., 1996. "Thresholds for Carcinogens: A Review of the Relevant Science and Its Implications for Regulatory Policy," Discussion Papers 10470, Resources for the Future.
    2. Fumie Yokota & George Gray & James K. Hammitt & Kimberly M. Thompson, 2004. "Tiered Chemical Testing: A Value of Information Approach," Risk Analysis, John Wiley & Sons, vol. 24(6), pages 1625-1639, December.
    3. Mehdi Razzaghi & David W. Gaylor, 1996. "On the Correlation Coefficient Between the TD50 and the MTD," Risk Analysis, John Wiley & Sons, vol. 16(1), pages 107-113, February.
    4. Resha M. Putzrath & James D. Wilson, 1999. "Fundamentals of Health Risk Assessment. Use, Derivation, Validity and Limitations of Safety Indices," Risk Analysis, John Wiley & Sons, vol. 19(2), pages 231-247, April.
    5. Pierre Crettaz & David Pennington & Lorenz Rhomberg & Kevin Brand & Olivier Jolliet, 2002. "Assessing Human Health Response in Life Cycle Assessment Using ED10s and DALYs: Part 1—Cancer Effects," Risk Analysis, John Wiley & Sons, vol. 22(5), pages 931-946, October.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:rff:dpaper:dp-96-21. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Resources for the Future (email available below). General contact details of provider: https://edirc.repec.org/data/rffffus.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.